Home » APPROVAL OF GUIDANT DEAL EXPECTED
APPROVAL OF GUIDANT DEAL EXPECTED
Shareholders are expected to vote overwhelmingly to approve Boston Scientific's proposed $27 billion takeover of Guidant in separate meetings this morning at their headquarters.
The New York Times (http://www.nytimes.com/2006/03/31/business/31device.html?_r=1&oref=slogin)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May